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Any physician involved in primary care will
encounter patients with menstrual dysfunction.
Mismanagement of this disorder is not usually
the result of its complexity but rather the lack of
an orderly approach. In unusual circumstances
one may encounter a patient with a menstrual
disorder of sufficient complexity to require refer
ral. This decision should be based on a work-up
indicating such a need rather than frustration af
ter unsuccessful empiric therapeutic trials.
The age of the patient is an important con
sideration for evaluation; the three main cate
gories are the adolescent, reproductive, and cli
macteric age groups.
Adolescent menstrual disorders are gen
erally the concerns of ''too early,'' ''too late'· or
"too much." Menarche, or the first period, is
expected to occur by age 13. "Too early"
would be prior to age 9 and "too late" would be
after 16.5 years of age. Those who have men
arche "too early" usually prove to be individ
uals who have undergone the normal sequential
events of puberty and have cyclic hypothalamic
and ovarian function. Only one out of ten of
these individuals will have any serious disorder
such as brain tumor, residual damage after
meningitis, or Albright disease. If menstruation
has occurred but cyclic function is absent and
ovulation does not take place, then a search for
a source of estrogen must be made, the two
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most common sources being exogenous estro
gen that has been ingested or endogenous es
trogen from a theca-granulosa cell tumor of the
ovary.
Therefore, the first effort is to determine if
the patient's condition reflects a full, orderly,
pubertal change or whether it represents only
the effect of estrogenic stimulation. If it appears
to be true puberty, an intracranial lesion must
then be ruled out. If it appears to be pseudo
precocious puberty from estrogen stimulation
with only menstrual bleeding, skeletal growth
and breast stimulation, then a source from the
environment or the ovaries must be sought.
About 95% of women will have had their
first menses by age 16.5 years and 99% by
age 18. A detailed history and thorough phys
ical examination will give a number of diagnos
tic clues to a physician confronted with a patient
who has not yet menstruated. Although it can
not be precisely predicted, there is a relatively
orderly sequence of events that occurs with pu
berty. The gradual elevation of estrogens is re
flected in the early development of the breasts,
and about one year later, the rapid increase in
the rate of skeletal growth. The adrenal
changes resulting in higher levels of circulating
androgens influence the growth of axillary and
public hair. The onset of the first period can be
expected within about 1 8 months of the rapid
growth spurt. Therefore, the history and phys
ical examination will give an indication at about
what level the problem exists. These patients
may present in a number of ways.
First, let us take a 17-year-old female who
has not menstruated and who has no secondary
sexual characteristics. We know immediately
that there are no significant amounts of estro-

years and that the hypothalamus and pituitary
must be functioning. Physical examination
would be expected to reveal some abnormality.
An obstruction to the menstrual flow such as im
perforate hymen might lead to a direct and
simple solution to the problem. Absence of the
uterus or vagina (or some combination thereof)
requires further evaluation. At this point some
physicians use a buccal smear, others a testos
terone determination, in order to identify the pa
tients with testicular feminization syndrome. If
the findings are positive for this diagnosis, then
gonadal removal is indicated after completion of
pubertal changes because of the risk of malig
nancy Gender identity for this person has al
ways been female and this should not be dis
rupted by informing the patient about the details
of the condition. If a normal testosterone level or
positive buccal smear is indicative of a genetic
female, then surgical vaginoplasty may be nec
essary, but gonadal removal is not necessary
since a Y chromosome is absent.
Third, we may be faced with a 17-year-old
female with a nt,, mal history of puberty, normal
secondary sexual characteristics, and both va-

gen being made in that individual and must de
termine whether the gonads are at fault or if the
disorder is central. A determination of follicle
stimulating hormone (FSH) and luteinizing hor
mone (LH) from plasma will divide these pa
tients into two groups. If the gonadotropins are
elevated, we know that we are dealing with pri
mary gonadal failure and must obtain genetic
studies by karyotyping. The usual abnormal kar
yotypes found are 45X, 46 abnormal X, 46XX,
and mosaics. If the gonadotropins are low, we
are dealing with a central defect. The availability
of gonadotropin-releasing hormone will allow
the identification of those who have a hypotha
lamic dysfunction from those with an anterior pi
tuitary dysfunction but this hormone is not now
generally available. At present, the method of
management for all of these cases will be estro
gen/progestin substitution therapy.
Second, we consider a 17-year-old with
primary amenorrhea who by history had breast
development beginning at age 11 , a growth
spurt evident by age 1 2, and normal axillary
and pubic hair. We would know that her gonads
had been producing sex steroids for several
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gina and uterus present. The evaluation of this
individual would be the same as for the woman
who has previously had menstrual function but
who now has secondary amenorrhea. First,
pregnancy should be ruled out. This may be
done by a progestin or progesterone withdrawal
test or by a beta human chorionic gonadotropin
(BHCG) pregnancy test. The latter is probably
now preferred because of the alleged terato
genic effect of hormones when pregnancy does
exist. Once pregnancy is ruled out, a progestin
or progesterone withdrawal test may be per
formed to evaluate the level of circulating estro
gen, although the status of the endometrium
and patency of the cervix would also influence
the outcome. Eventually, however, in these pa
tients a determination of FSH, LH and estradiol
will be necessary to categorize the patient as in
dicated in the flow sheet (Figure 1)
The adolescent with "too much" bleed
ing, who is otherwise normal, is most likely ex
periencing anovulatory cycles. The diethylstil
bestrol (DES) problem has made it important
that visualization of the vagina and cervix be
carried out. However, it is not necessary to
biopsy or curette the endometrium of these indi
viduals except under unusual circumstances.
Management is usually by the administration of
oral contraceptives to control the cycles, and
oral iron to replenish its loss.
During the reproductive age a variety of
menstrual disorders may be found also. For
those women whose menstrual function has
ceased (secondary amenorrhea) we can follow
the course of evaluation previously outlined for
the anatomically and genetically normal adoles
cent. For all other disturbances of the cycles,
where bleeding is not of sufficient magnitude as
to create an urgent problem, it is necessary to
rule out pregnancy and to determine whether or
not ovulation is occurring. If the patient has ex
cessive menstrual flow or intermenstrual bleed-

ing with good evidence of ovulation (by basal
body temperature, progesterone assay or endo
metrial biopsy) then coagulation disorders
should be ruled out and dilatation and curettage
performed. If anovulation is demonstrated, en
dometrial sampling is prudent for those women
at the end of the reproductive scale to rule out
abnormal hyperplasia or the rare carcinoma. In
general, however, these patients can be treated
by either combined oral contraceptives in a cy
clic manner or by one week of oral progestin
each month. When anovulation occurs it is im
portant to recognize that there is a wide variety
of emotional, endocrine and general health dis
turbances that may interfere with the menstrual
cycle Therefore, evaluation of the patient must
be general and thorough in order that symp
toms and signs of other disorders may be
found.
Menstrual change in the climacteric is ex
pected as anovulation becomes more frequent
and ovarian function progressively declines.
However, some patients will experience exces
sive bleeding and/or unpredictable frequent
episodes of bleeding. The possibility of preg
nancy still exists in this age group and must be
considered. However, the most important re
quirement for these women is the sampling of
the endometrium. Subsequent management de
pends upon the pathologist's findings and is
outlined in Figure 2.
In summary, control of menstrual function
is a very complex system that is highly in
tegrated and subject to a number of types of
malfunction from both within and without. Identi
fication of the majority of menstrual disorders is
within the reach of physicians responsible for
primary care but requires a thoughtful, orga
nized approach. Inability to reach a satisfactory
diagnosis or lack of response by the patient to
established methods of therapy indicate the
need for more intensive evaluation.

